Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.
Saved in:
| Title: | Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer. |
|---|---|
| Authors: | Song PN; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Graduate Biomedical Sciences, The University of Alabama at Birmingham, Birmingham, USA., Cingoranelli SJ; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Sridhar S; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA., Houson HA; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Gallegos CA; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA., Watts LB; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA., Bartels JL; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Willey CD; Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA., Lapi SE; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: lapi@uab.edu., Sorace AG; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: asorace@uabmc.edu. |
| Source: | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 Jul 21; Vol. 202, pp. 119736. Date of Electronic Publication: 2026 Jul 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42480146 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development and characterization of [<superscript>47</superscript>Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Song+PN%22">Song PN</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Graduate Biomedical Sciences, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Cingoranelli+SJ%22">Cingoranelli SJ</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Sridhar+S%22">Sridhar S</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Houson+HA%22">Houson HA</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Gallegos+CA%22">Gallegos CA</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Watts+LB%22">Watts LB</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Bartels+JL%22">Bartels JL</searchLink>; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Willey+CD%22">Willey CD</searchLink>; Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA.<br /><searchLink fieldCode="AU" term="%22Lapi+SE%22">Lapi SE</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: lapi@uab.edu.<br /><searchLink fieldCode="AU" term="%22Sorace+AG%22">Sorace AG</searchLink>; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: asorace@uabmc.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228213295%22">Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie</searchLink> [Biomed Pharmacother] 2026 Jul 21; Vol. 202, pp. 119736. <i>Date of Electronic Publication: </i>2026 Jul 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>8213295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1950-6007 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207533322%22">07533322 </searchLink><i>NLM ISO Abbreviation: </i>Biomed Pharmacother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42480146 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.biopha.2026.119736 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 119736 Titles: – TitleFull: Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Song PN – PersonEntity: Name: NameFull: Cingoranelli SJ – PersonEntity: Name: NameFull: Sridhar S – PersonEntity: Name: NameFull: Houson HA – PersonEntity: Name: NameFull: Gallegos CA – PersonEntity: Name: NameFull: Watts LB – PersonEntity: Name: NameFull: Bartels JL – PersonEntity: Name: NameFull: Willey CD – PersonEntity: Name: NameFull: Lapi SE – PersonEntity: Name: NameFull: Sorace AG IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 07 Text: 2026 Jul 21 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1950-6007 Numbering: – Type: volume Value: 202 Titles: – TitleFull: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Type: main |
| ResultId | 1 |